美国介入疼痛医师学会(ASIPP)指南:COVID-19期间重返介入疼痛实践的循证风险缓解与分层
美国介入疼痛医师学会(ASIPP)成立COVID-ARMS重返实践工作组,为COVID-19大流行期间介入疼痛诊疗的安全有序恢复提供指导。方法包括设定目标与关键问题、利益冲突披露及多区域多专业专家组,复习COVID-19流行病学、危险因素、并发症、发病率与死亡率及风险缓解分层文献;因COVID-19相关文献有限,未采用AHRQ证据分级,指南被视为证据知情。结果指出老年及基础肺病或心血管病等合并症与更差结局相关,COVID-19患者表现异质,需个案评估;创建COVID-ARMS风险分层工具快速客观评估患者。结论强调疼痛患者需持续照护,应分层风险、保护患者免于感染,优化远程医疗,按个案评估风险获益,可先从低风险患者恢复诊疗并采取适当防护。
要点
- 美国介入疼痛医师学会(ASIPP)发布COVID-ARMS风险分层工具,用于快速客观评估介入疼痛患者。
- 老年及基础肺病或心血管病等合并症与COVID-19更差结局相关。
- COVID-19患者表现异质,需按个案评估并制定个体化照护建议。
- 疼痛专科医师应优化远程医疗 encounters,并认知COVID-19发病风险。
- 疼痛专科医师可先从低风险患者恢复诊疗,并采取适当防护措施。
适用人群与场景
- 介入疼痛专科医师及其慢性疼痛患者,适用于COVID-19大流行期间重返介入疼痛诊疗的场景。
- COVID-19患者为异质群体,部分个体相对健康且仅有短期可控症状,另一些则病情危重。
诊断标准与关键阈值
- 使用COVID-ARMS风险分层工具对患者进行快速客观评估。
处置流程与药物剂量
- 疼痛专科医师应优化与疼痛患者的远程医疗 encounters。
- 疼痛专科医师应认知COVID-19发病风险,并按个案评估风险获益。
- 疼痛专科医师可先从低风险患者恢复诊疗,并采取适当防护措施。
研究设计与关键结果
- 美国介入疼痛医师学会(ASIPP)成立COVID-ARMS重返实践工作组,提供COVID-19大流行期间介入疼痛诊疗安全战略重启的指导。
- 方法包括设定目标与关键问题、利益冲突披露及多区域多专业专家组,复习COVID-19流行病学、危险因素、并发症、发病率与死亡率及风险缓解分层文献。
- 因COVID-19、风险缓解与分层文献有限,未采用AHRQ最佳证据合成与推荐分级原则,指南被视为证据知情,整合最佳可得研究与实践中知识。
- 老年及某些合并症(如基础肺病或心血管病)与更差结局相关。
- 创建COVID-ARMS风险分层工具以快速客观评估患者。
证据类型、等级与局限
- 证据类型:指南(美国介入疼痛医师学会,ASIPP)。
- 因COVID-19相关文献有限,未采用AHRQ证据分级,指南被视为证据知情。
- 局限:制定推荐时COVID-19为持续大流行,证据知情指导处于动态变化中;随着更多更好证据积累,这些推荐可能被修改。
对床旁实践的改变
- 介入疼痛专科医师可按个案评估风险获益,优化远程医疗,并先从低风险患者恢复诊疗并采取适当防护。
- 作者认为介入疼痛专科医师及其患者可能从证据知情风险分层、预防感染的保护策略及逐步恢复治疗与操作中获益。
指南或共识出处
- 指南名称:Evidence-Based Risk Mitigation and Stratification During COVID-19 for Return to Interventional Pain Practice: American Society of Interventional Pain Physicians (ASIPP) Guidelines;发布机构:美国介入疼痛医师学会(ASIPP);来源期刊:Pain Physician。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Chronic pain patients require continuity of care even during the COVID-19 pandemic, which has drastically changed healthcare and other societal practices. The American Society of Interventional Pain Physicians (ASIPP) has created the COVID-ASIPP Risk Mitigation & Stratification (COVID-ARMS) Return to Practice Task Force in order to provide guidance for safe and strategic reopening.
OBJECTIVES: The aims are to provide education and guidance for interventional pain specialists and their patients during the COVID-19 pandemic that minimizes COVID-related morbidity while allowing a return to interventional pain care.
METHODS: The methodology utilized included the development of objectives and key questions with utilization of trustworthy standards, appropriate disclosures of conflicts of interest, as well as a panel of experts from various regions, specialities, and groups. The literature pertaining to all aspects of COVID-19, specifically related to epidemiology, risk factors, complications, morbidity and mortality, and literature related to risk mitigation and stratification were reviewed. The principles of best evidence synthesis of available literature and grading for recommendations as described by the Agency for Healthcare Research and Quality (AHRQ) typically utilized in ASIPP guideline preparation was not utilized in these guidelines due to limitations because of their lack of available literature on COVID-19, risk mitigation and stratification. These guidelines are considered evidence -- informed with incorporation of best available research and practice knowledge. Consequently, these guidelines are considered evidence-informed with incorporation of best available research and practice knowledge.
RESULTS: Numerous risk factors have emerged that predispose patients to contracting COVID-19 and/or having a more severe course of the infection. COVID-19 may have mild symptoms, even be asymptomatic, or may be severe and life threatening. Older age and certain comorbidities, such as underlying pulmonary or cardiovascular disease, have been associated with worse outcomes. In pain care, COVID-19 patients are a heterogeneous group with some individuals relatively healthy and having only a short course of manageable symptoms while others become critically ill. It is necessary to assess patients on a case-by-case basis and craft individualized care recommendations. A COVID-ARMS risk stratification tool was created to quickly and objectively assess patients. Interventional pain specialists and their patients may derive important benefits from evidence-informed risk stratification, protective strategies to prevent infection, and the gradual resumption of treatments and procedures to manage pain.
LIMITATIONS: COVID-19 was an ongoing pandemic at the time during which these recommendations were developed. The pandemic has created a fluid situation in terms of evidence-informed guidance. As more and better evidence is gathered, these recommendations may be modified.
CONCLUSIONS: Chronic pain patients require continuity of care but during the time of the COVID-19 pandemic, steps must be taken to stratify risks and protect patients from possible infection to safeguard them from COVID-19-related illness and transmitting the disease to others. Pain specialists should optimize telemedicine encounters with their pain patients, be cognizant of risks of COVID-19 morbidity, and take steps to evaluate risk-benefit on a case-by-case basis. Pain specialists may return to practice with lower-risk patients and appropriate safeguards.
参考来源
- Shah S, Diwan S, Soin A, et al. Evidence-Based Risk Mitigation and Stratification During COVID-19 for Return to Interventional Pain Practice: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician. 2020. PMID: 32942784
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。